Clinical Trial: Efficacy and Safety of Extended-Course Budesonide Enteric Capsules in Patients with Primary IgA Nephropathy: A Single-Center Prospective Cohort Study (China)

Posted On: 2026-08-21

China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Extended-Course Budesonide Enteric Capsules in Patients with Primary IgA Nephropathy: A Single-Center Prospective Cohort Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130506

Registration Time: 2026/08/20

Type: Observational study

Primary Sponsor: The First Affiliated Hospital of Dalian Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338679

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Efficacy and Safety of Extended-Course Budesonide Enteric Capsules in Patients with Primary IgA Nephropathy: A Single-Center Prospective Cohort Study (China)